RESUMEN
A patient who underwent a transfusion due to an aplastic anemia subsequently experienced secondary hemochromatosis, which is very rare in Korea. The 56 year old female was admitted to our hospital with complaints of general weakness, fatigue, a brown-colored facial complexion, dyspnea upon exertion, and abdominal distension. Laboratory examination disclosed functional impairment of the liver and echocardiography revealed a congestive heart failure pattern. Gastrofiberscopy revealed brown colored gastric mucosa, and a fundal mucosa biopsy revealed a hemosidt pigment in iron stain.
Asunto(s)
Femenino , Humanos , Persona de Mediana Edad , Anemia Aplásica , Biopsia , Disnea , Ecocardiografía , Fatiga , Mucosa Gástrica , Insuficiencia Cardíaca , Hemocromatosis , Hierro , Corea (Geográfico) , Hígado , Membrana MucosaRESUMEN
Granulocytic sarcoma is a localized tumor mass composed of immature cells of the granulocytic series. It can develope in patients with acute myelogenous leukemia or impending blast crisis of chronic myelogenous leukemia. Granulocytic sarcoma during the course of chronic myelogenous leukemia has beeen noted to occur in lymph node, bone, skin, breast, peritoneum, testis, ovary, gastrointestinal tract, kidney, brain. We reported a case of granulocytic sarcoma causing spinal cord compression in chronic myelogenous leukemia with a brief review of literature.
Asunto(s)
Femenino , Humanos , Crisis Blástica , Encéfalo , Mama , Tracto Gastrointestinal , Riñón , Leucemia Mielógena Crónica BCR-ABL Positiva , Leucemia Mieloide Aguda , Ganglios Linfáticos , Ovario , Peritoneo , Sarcoma Mieloide , Piel , Compresión de la Médula Espinal , Médula Espinal , TestículoRESUMEN
Essential thrombocythemia is a myeloproliferative disorder, characterized by marked thrombocytosis and marrow megakaryocytic hyperplasia. Although the major causes of morbidity and mortality are bleeding and thromboembolic events, the long-term prognosis is favorable and leukemic transformation is rare. We report a case of acute leukemia following treatment of Philadelphia chromosome-negative essential thrombocythemia with hydroxyurea for 4 years with a brief review of literature.